National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$59.75
add to cart

Rights & Permissions

topleft topright

Medicare: New Directions in Quality Assurance Proceedings (1991)
Institute of Medicine (IOM)

Citation Manager

. "26. Where Do We Go From Here?." Medicare: New Directions in Quality Assurance Proceedings. Washington, DC: The National Academies Press, 1991.

Please select a format:

BibTeX EndNote RefMan


Page
199
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Medicare: New Directions in Quality Assurance

come together to press for the legislative and administrative changes called for.

Why should such an effort be undertaken? If it is undertaken, will it succeed? Why should it be supported? I think the shift of definition of purpose—to achieving outcomes for patients—is very important. It needs to be understood, internalized, and externalized, and I have come to understand that this shift in purpose represents a major cultural change. It does not come overnight. It does not come because we all sit here and agree with one another. The changes need a broad and public appreciation and understanding.

PATIENT OUTCOMES

The shift to outcomes is not just a technical process. The more I look at this, the more I think we have been obsessed in this country with reducing risk through accuracy and data collection. We have gotten so carried away that we believe that if it is not measurable, it is not real. The fact that we now have outcomes and health status measures that are broader than our physiologic measures is, I think, critical to our ability to make the shift to a broader definition of quality and outcome. We can measure things now—accurately, reliably, and repeatedly—that simply were not available in the past to be measured and incorporated into a quality assurance effort.

Within the issue of outcomes, functional status, and satisfaction is another critical shift—namely, a redressing of the balance between those of us who give care and those of us who receive it. There must be a growing understanding that this is a partnership and that we cannot do it alone. Patient preferences, patient control, and levels of patient compliance do affect outcomes. That is one important theme that must be more broadly understood as well as written into legislation.

EMPHASIZING PROFESSIONALISM

I believe that we need to understand the culture of physicians and hospitals with the objective of getting medical care providers to internalize this broader view of their objectives and roles. Someone asked whether hospitals were willing to look at outcomes. I must say I was a bit taken aback by that. I think many of us have been struggling with it as our purpose for being here. Some might resist, but I cannot imagine that they are very many in number.

The report calls for re-recognizing the role of the professional, re-recognizing some assumptions that people do have positive, virtuous goals. Yes, there are ''bad apples,'' but let us not concentrate all of our time and energy on them because as Relman (1991) says, "We have a lot of sullen people

Page
199
Front Matter (R1-R10)
Part 1: Introduction (1-2)
1. Introduction (3-6)
2. The Institute of Medicine Report (7-14)
Part 2: New Directions: More Professionalism, Less Regulation (15-17)
3. The Committee View (18-21)
4. A Response (22-26)
Part 3: New Directions: Organization- and System-Focused Quality Improvement (27-30)
5. The Committee View (31-36)
6. A Response (37-44)
Part 4: New Directions: Improved Decision-Making by Patients and Clinicians (45-47)
7. The Committee View (48-53)
8. A Response (54-58)
Part 5: New Directions: A Patient Outcomes Orientation (59-62)
9. The Committee View (63-72)
10. A Response (73-78)
Part 6: New Directions: Public Accountability and Program Evaluation (79-81)
11. The Committee View (82-85)
12. A Response (86-90)
Part 7: Confronting Special Implementation Issues (91-95)
13. The Epidemiology of Quality Problems (96-104)
14. Legal Concerns (105-115)
15. Translating the Institute of Medicine Report (116-126)
Part 8: New Directions: The Research, Training, and Capacity Building Agendas (127-129)
16. Research and Capacity Building: Issues Raised by the Institute of Medicine Report (130-139)
17. The Research Agenda: An Outside View (140-144)
18. The Training and Capacity Building Agendas: An Outside View (145-150)
Part 9: Response to the Institute of Medicine Report Recommendations (151-154)
19. A Legislator's Response to the Institute of Medicine Report (155-160)
20. A Legislator's Response to the Institute of Medicine Report (161-166)
21. A Physician's Response to the Institute of Medicine Report (167-173)
22. An Administration Response to the Institute of Medicine Report from the Agency for Health Care Policy and Research (174-178)
23. An Administration Response to the Institute of Medicine Report from the Health Care Financing Administration (179-185)
24. A Peer Review Organization Response to the Institute of Medicine Report (186-190)
Part 10: Where Do We Go From Here? (191-193)
25. Where Do We Go From Here? (194-197)
26. Where Do We Go From Here? (198-204)
List of Authors (205-208)